Growth Of Biosimilars

Expected launches and uptake are likely to increase overall spending on biosimilars significantly to $20–$49Bn in 2027 and cumulative sales of ...

Biosimilars are a promising product category, one that can provide patients and doctors with more affordable treatment options.

The global biosimilar market is projected to surge from $25.1 billion in 2022 to approximately $1.3 trillion by 2032, with a compound annual ...

The Booming Market of Biosimilars - AlphaSense

Overall, the biosimilar market continues to expand around the world. Valued at $20.44 billion in 2022, the market size is projected to grow from ...

According to a new market research report, the global biosimilars market size was USD 29.45 billion in 2023, calculated at USD 34.66 billion ...

A Milestone in Facilitating the Development of Biosimilars - FDA

the FDA approved the 50th biosimilar, reflecting the markedly increased availability of biosimilar products—products that treat a wide range of ...

Three imperatives for R&D in biosimilars - McKinsey & Company

The US market has seen the fastest growth in biosimilars, with a CAGR of 97 percent from 2015 to 2021, compared with 48 percent in Europe and 39 ...

The Economics of Biosimilars - PMC

6 Moreover, the complexity of monoclonal antibodies makes their development and manufacturing costs much higher than for the biosimilars that are currently on ...

Navigating Growth: Insights into the Expanding Global Biosimilars ...

Several factors drive the growth of the biosimilar market. The most important is the patent expiration of high-cost blockbuster biologics like Humira® and ...

Expert Reflects on Trends, US Market of Biosimilars in 2023

Gregory sheds light on the rapid growth observed in biosimilar development, emphasizing therapeutic areas such as oncology supportive care, ...

Biosimilars market growth is primed to transition from 29.4 billion in 2023 to USD 66.9 billion by 2028, showcasing a strong CAGR of 17.8%.

In the IQVIA Use of Medicines in the US 2024 report, biosimilars were found to be large contributors to lower drug costs and drivers of ...

Samsung Bioepis Reports 2024 Biosimilar Market Growth Trends

The market share has increased an average of 53% after the first 5 years of post-initial biosimilar launch. Biosimilars can be categorized by ...

As the biosimilars market continues to grow and shift more squarely into the pharmacy benefit, we will expect to see commensurate growth in the ...

The global biosimilars market size was valued at USD 21.8 billion in 2022 and is expected to grow at a CAGR of 15.9% over the forecast period.

Currently, 13% of biosimilar products in development are being developed by six large pharma companies. The remaining 87% are being developed by ...

An inflection point for biosimilars - McKinsey & Company

Biosimilars continue to post monumental growth. Estimates suggest that global sales topped $15 billion in 2020, representing a compound annual ...

The Future of Biosimilars: Trends and Predictions - mAbxience

This article explores the dynamic landscape of biosimilars, highlighting the key trends, products and strategic considerations that will dictate the future of ...

Current Status of Biosimilars and Their Impact on Pharmacovigilance

However, pricing remains relatively stable due to the lengthy and expensive development process of biosimilars, which takes between eight to ten ...

Expected Impact of Biosimilars on the Pharmaceutical Companies

Biosimilar products have caused a more positive impact on pharmaceutical companies and could lead to expansion of this industry due to the profits gained from ...